TY - JOUR
T1 - Population pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014)
AU - Sosa-Macias, Martha
AU - Moya, Graciela E.
AU - Llerena, Adrián
AU - Ramírez, Ronald
AU - Terán, Enrique
AU - Penãs-Lledó, Eva M.
AU - Tarazona-Santos, Eduardo
AU - Galaviz-Hernández, Carlos
AU - Céspedes-Garro, Carolina
AU - Acosta, Hildaura
N1 - Publisher Copyright:
© 2015 Future Medicine Ltd.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - MESTIFAR 2014 28-30 November 2014, Panama City, Panama The CEIBA consortium was created within the Ibero-American network of Pharmacogenetics (RIBEF) to study population pharmacogenetics. The current status of these initiatives and results of the MESTIFAR project were analyzed in Panama, 28-30 November 2014. The MESTIFAR project focused on studying CYPs genetic polymorphisms in populations of different ethnic origin. So far, more than 6000 healthy volunteers have been evaluated, making this one of the largest population pharmacogenomic studies worldwide. Three symposia were organized, 'Pharmacogenetics of indigenous and mestizos populations and its clinical implications', 'Methodological innovation in pharmacogenetics and its application in health', and 'General discussion and concluding remarks', about mechanisms and proposals for training, diffusion of pharmacogenetics for Spanish-and Portuguese-speaking health professionals, and 'bench to bedside' pilot projects.
AB - MESTIFAR 2014 28-30 November 2014, Panama City, Panama The CEIBA consortium was created within the Ibero-American network of Pharmacogenetics (RIBEF) to study population pharmacogenetics. The current status of these initiatives and results of the MESTIFAR project were analyzed in Panama, 28-30 November 2014. The MESTIFAR project focused on studying CYPs genetic polymorphisms in populations of different ethnic origin. So far, more than 6000 healthy volunteers have been evaluated, making this one of the largest population pharmacogenomic studies worldwide. Three symposia were organized, 'Pharmacogenetics of indigenous and mestizos populations and its clinical implications', 'Methodological innovation in pharmacogenetics and its application in health', and 'General discussion and concluding remarks', about mechanisms and proposals for training, diffusion of pharmacogenetics for Spanish-and Portuguese-speaking health professionals, and 'bench to bedside' pilot projects.
KW - Ibero-Americans populations
KW - cytochrome P450
KW - drug metabolism
KW - genome-wide analyses
KW - metabolic phenotypes
KW - next-generation sequencing
KW - pharmacogenetics
KW - population genetics
UR - http://www.scopus.com/inward/record.url?scp=84930690410&partnerID=8YFLogxK
U2 - 10.2217/pgs.15.32
DO - 10.2217/pgs.15.32
M3 - Artículo
C2 - 25929854
AN - SCOPUS:84930690410
SN - 1462-2416
VL - 16
SP - 673
EP - 676
JO - Pharmacogenomics
JF - Pharmacogenomics
IS - 7
ER -